Cite
HARVARD Citation
Javier Escalada, F. et al. (2018). Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment. Diabetes, obesity & metabolism. 20 (12), pp. 2860-2868. [Online].